Literature DB >> 6312573

[An original treatment of sleep disorders, anxiety and agitation in elderly patients: tiapride].

S M Taillefer, P Sauvage.   

Abstract

Forty-five elderly patients (mean age: 82 years), previously under benzodiazepines or neuroleptics, were given tiapride in a daily dosage of 100 to 400 mg for 2 to 4 months, usually by the oral route. The symptomatic effect of tiapride on agitation, excitability, unstability and sleep disturbances was excellent in 27 cases, satisfactory in 11, average in 5 and absent in 2. In 22 patients, tiapride produced significant improvement in morning wakefulness with increased diurnal activity and improved relationships and memory. The latency interval is variable, depending on the half-life of the benzodiazepine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312573

Source DB:  PubMed          Journal:  Sem Hop


  2 in total

1.  Release hallucinations and tiapride.

Authors:  R Badino; M Trucco; A Caja; I Del Conte; C Guida; M Ivaldi
Journal:  Ital J Neurol Sci       Date:  1994-05

Review 2.  Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation.

Authors:  J W Steele; D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.